No ratings yet
Taught by or worked with Derek? Your rating helps other students choose.
Professor Derek Gilroy is a leading academic in the field of experimental inflammation at University College London. He serves as Professor of Experimental Inflammation and Head of the Department of Experimental and Translational Medicine within the Faculty of Medical Sciences, Division of Medicine. His research focuses on the mechanisms of inflammation and its resolution, with particular emphasis on pro-resolution pathways and their potential to address chronic inflammatory diseases.
Professor Gilroy obtained his PhD in 1997 from the William Harvey Research Institute at the University of London. He joined University College London and was appointed Professor of Experimental Immunology in 2010. In addition to his academic roles, he is the founder and CEO of Penta Therapeutics. His work has contributed to advancing understanding of inflammatory processes and therapeutic approaches in immunology and experimental medicine.
Dive into UCL's breakthrough on epoxy-oxylipins, fat-derived molecules acting as the body's inflammation off-switch, offering new hope for arthritis, heart disease, and more.
UCL scientists reveal epoxy-oxylipins as the body's inflammation off switch, reducing chronic disease risk via sEH inhibition. Key implications for RA, IBD in UK.
Photo by Antoine Dautry on Unsplash
Photo by Chris Liverani on Unsplash
Photo by Peter Burdon on Unsplash
Photo by Andrii Zhuk on Unsplash
Photo by EESOFUFFZICH on Unsplash
Photo by Google DeepMind on Unsplash
Photo by Gabriele Malaspina on Unsplash
